Detalles de la búsqueda
1.
Joint analysis of PK and immunogenicity outcomes using factorization model - a powerful approach for PK similarity study.
BMC Med Res Methodol
; 22(1): 264, 2022 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36209046
2.
Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration.
Proc Natl Acad Sci U S A
; 113(43): 12304-12309, 2016 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27791020
3.
Ex vivo comparative immunogenicity assessment (EVCIA) to determine relative immunogenicity in chronic plaque psoriasis in participants receiving Humira® or undergoing repeated switches between Humira® and AVT02.
Immunother Adv
; 4(1): ltad029, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38268817
4.
A multicenter, randomized, open-label, 2-arm parallel study to compare the pharmacokinetics, safety and tolerability of AVT02 administered subcutaneously via prefilled syringe or autoinjector in healthy adults.
Expert Opin Biol Ther
; 23(8): 773-780, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36197309
5.
Assessment of real-life patient handling experience of AVT02 administered subcutaneously via autoinjector in patients with moderate to severe active rheumatoid arthritis: an open-label, single-arm clinical trial, then an extension phase of AVT02 administered with a prefilled syringe.
Expert Opin Biol Ther
; 23(8): 781-789, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36205514
6.
In vivo imaging of choroidal angiogenesis using fluorescence-labeled cationic liposomes.
Mol Vis
; 18: 1045-54, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22605917
7.
A randomized, adaptive design, double-blind, 3-arm, parallel study assessing the pharmacokinetics and safety of AVT02, a high-concentration (100 mg/mL) Adalimumab biosimilar, in healthy adult subjects (ALVOPAD FIRST).
Expert Opin Investig Drugs
; 31(9): 965-976, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35107050
8.
Comparison of lung accumulation of cationic liposomes in normal rats and LPS-treated rats.
Inflamm Res
; 60(3): 245-53, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20938712
9.
Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study.
BioDrugs
; 35(6): 735-748, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34657274
10.
Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer.
Int J Cancer
; 126(5): 1235-45, 2010 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19697323
11.
Maternal HIV type 1 infection suppresses MMP-1 expression in endothelial cells of uninfected newborns: nonviral vertical transmission of HIV type 1-related effects.
AIDS Res Hum Retroviruses
; 21(11): 940-4, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16386110
12.
Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells.
Biochem J
; 379(Pt 2): 409-20, 2004 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14741045
13.
Antagonistic TNF receptor one-specific antibody (ATROSAB): receptor binding and in vitro bioactivity.
PLoS One
; 8(8): e72156, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23977237
14.
EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX.
Blood
; 105(8): 3263-9, 2005 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15613549
15.
The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression.
EMBO J
; 22(15): 3772-82, 2003 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12881412
16.
Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases.
Am J Pathol
; 161(5): 1749-59, 2002 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-12414522
Resultados
1 -
16
de 16
1
Próxima >
>>